Pharma News
CB-11 by Cellebrain for Glioblastoma Multiforme (GBM): Likelihood of Approval
CB-11 is under clinical development by Cellebrain and currently in Phase I for Glioblastoma Multiforme (GBM).
Source link
#CB11 #Cellebrain #Glioblastoma #Multiforme #GBM #Likelihood #Approval